Orexigen to Seek FDA Approval for Contrave

Orexigen Therapeutics said it would seek regulatory approval from U.S. regulators for its anti-obesity treatment Contrave



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303281504579220050484445992.html?mod=pls_whats_news_us_business_f

via IFTTT